Role of the angiopoietin-like protein family in the progression of NAFLD

被引:2
|
作者
Su, Xin [1 ]
Xu, Qinchen [1 ]
Li, Zigan [1 ]
Ren, Yidan [2 ]
Jiao, Qinlian [2 ]
Wang, Lina [1 ]
Wang, Yunshan [2 ]
机构
[1] Shandong Univ, Hosp 2, Cheeloo Coll Med, Dept Clin Lab, Jinan 250033, Shandong, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Clin Lab, Jinan 250021, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
NAFLD; Angiopoietin-like protein; Hepatocellular carcinoma; Metabolic syndrome; NONALCOHOLIC FATTY LIVER; HUMAN HEPATOCELLULAR-CARCINOMA; EX-VIVO EXPANSION; GROWTH-FACTOR; LIPID-METABOLISM; CALORIC RESTRICTION; CLINICAL-PATTERNS; MOLECULAR-CLONING; TUMOR-METASTASIS; SCORING SYSTEMS;
D O I
10.1016/j.heliyon.2024.e27739
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of chronic liver disease, with a range of conditions including non-alcoholic fatty liver, non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Currently recognized as the liver component of the metabolic syndrome, NAFLD is intimately linked to metabolic diseases. Angiopoietin-like proteins (ANGPTLs) comprise a class of proteins that resemble angiopoietins structurally. It is closely related to obesity, insulin resistance and lipid metabolism, and may be the critical factor of metabolic syndrome. In recent years, many studies have found that there is a certain correlation between ANGPTLs and the occurrence and progression of NAFLD disease spectrum. This article reviews the possible mechanisms and roles of ANGPTL protein in the pathogenesis and progression of NAFLD.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunity
    Horiguchi, Haruki
    Kadomatsu, Tsuyoshi
    Kurahashi, Ryoma
    Hara, Chiaki
    Miyata, Keishi
    Baba, Masaya
    Osumi, Hironobu
    Terada, Kazutoyo
    Araki, Kimi
    Takai, Toshiyuki
    Kamba, Tomomi
    Linehan, W. Marston
    Moroishi, Toshiro
    Oike, Yuichi
    GENES & DEVELOPMENT, 2019, 33 (23-24) : 1641 - 1656
  • [33] Atypical angiopoietin-like protein that regulates ANGPTL3
    Quagliarini, Fabiana
    Wang, Yan
    Kozlitina, Julia
    Grishin, Nick V.
    Hyde, Rhonda
    Boerwinkle, Eric
    Valenzuela, David M.
    Murphy, Andrew J.
    Cohen, Jonathan C.
    Hobbs, Helen H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (48) : 19751 - 19756
  • [34] Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4
    Ge, HF
    Yang, GQ
    Huang, L
    Motola, DL
    Pourbahrami, T
    Li, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (03) : 2038 - 2045
  • [35] Angiopoietin-like Protein 3 AND Cardiovascular Disease: A Mini Review
    Rai, Srinidhi
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (51A) : 169 - 172
  • [36] Angiopoietin-like protein 2 contributes to pathogenesis of diabetic retinopathy
    Ito, Y.
    Oike, Y.
    Tanihara, H.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [37] Angiopoietin-like protein 2 is a positive regulator of osteoblast differentiation
    Takano, Aiko
    Fukuda, Takao
    Shinjo, Takanori
    Iwashita, Misaki
    Matsuzaki, Etsuko
    Yamamichi, Kensuke
    Takeshita, Masaaki
    Sanui, Terukazu
    Nishimura, Fusanori
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 69 : 157 - 170
  • [38] Secretion of angiopoietin-like 4 protein from intestinal cells
    Nielsen, Soren Drud
    Jessen, Randi
    Dalsgaard, Trine Kastrup
    Young, Jette Feveile
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2015, 5 (02): : 57 - 66
  • [39] Angiopoietin-like protein 2 as a potential biomarker for colorectal cancer
    Yoshinaga, Takuma
    Shigemitsu, Takamasa
    Nishimata, Hiroto
    Kitazono, Masaki
    Hori, Emiko
    Tomiyoshi, Ayako
    Takei, Takayuki
    Yoshida, Masahiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (05) : 1080 - 1084
  • [40] Angiopoietin-Like Protein 2 is a Critical Inflammatory Mediator of Atherosclerosis
    Horio, Eiji
    Kaikita, Koichi
    Miyata, Keishi
    Kadomatsu, Tsuyoshi
    Tazume, Hirokazu
    Zhe, Tian
    Tsujita, Kenichi
    Tayama, Shinji
    Hokimoto, Seiji
    Sugiyama, Seigo
    Takeya, Motohiro
    Ogawa, Hisao
    Oike, Yuichi
    CIRCULATION, 2012, 126 (21)